• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19.

作者信息

Zeng Guangting, Wang Linlin, Li Jianqiang, Zhang Zanling

机构信息

Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China.

Department of Pharmacy, Cancer Center(Xiamen), Fudan University, Xiamen, China.

出版信息

J Med Virol. 2023 Jun;95(6):e28836. doi: 10.1002/jmv.28836.

DOI:10.1002/jmv.28836
PMID:37247396
Abstract
摘要

相似文献

1
Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19.阿兹夫定与奈玛特韦-利托那韦对比治疗新冠肺炎住院患者的真实世界疗效
J Med Virol. 2023 Jun;95(6):e28836. doi: 10.1002/jmv.28836.
2
Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.阿兹夫定与奈玛特韦-利托那韦治疗住院COVID-19患者的真实世界有效性：一项回顾性队列研究。
J Med Virol. 2023 Apr;95(4):e28756. doi: 10.1002/jmv.28756.
3
Real-world effectiveness of nirmatrelvir-ritonavir versus azvudine in hospitalized patients with COVID-19 during the omicron wave in Beijing: a multicenter retrospective cohort study.奥密克戎变异株流行期间奈玛特韦片/利托那韦片与阿兹夫定治疗北京地区 COVID-19 住院患者的真实世界疗效：一项多中心回顾性队列研究。
BMC Infect Dis. 2024 Jan 8;24(1):57. doi: 10.1186/s12879-023-08965-8.
4
Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial.阿兹夫定和奈玛特韦/利托那韦在中重度 COVID-19 住院患者中的应用：一项随机目标试验的模拟。
J Med Virol. 2023 Dec;95(12):e29318. doi: 10.1002/jmv.29318.
5
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study.阿兹夫定、莫努匹韦和奈玛特韦/利托那韦在轻中度 COVID-19 成年患者中的比较：一项回顾性队列研究。
Sci Rep. 2024 Feb 9;14(1):3318. doi: 10.1038/s41598-024-53862-y.
6
Antiviral effect of azvudine and nirmatrelvir-ritonavir among hospitalized patients with COVID-19.阿兹夫定与奈玛特韦-利托那韦对新冠病毒感染住院患者的抗病毒作用。
J Infect. 2023 Jun;86(6):e158-e160. doi: 10.1016/j.jinf.2023.03.023. Epub 2023 Mar 30.
7
Effectiveness of the antiviral medications azvudine and nirmatrelvir-ritonavir in treating COVID-19 in patients with hematological malignancies.抗新冠病毒药物阿兹夫定和奈玛特韦-利托那韦在治疗血液系统恶性肿瘤患者 COVID-19 中的疗效。
Clinics (Sao Paulo). 2024 Jul 25;79:100406. doi: 10.1016/j.clinsp.2024.100406. eCollection 2024.
8
Effectiveness and safety of azvudine versus nirmatrelvir-ritonavir in adult patients infected with COVID-19 omicron strains: a retrospective study in Beijing.阿兹夫定对比奈玛特韦/利托那韦在奥密克戎变异株感染成年患者中的有效性和安全性：一项北京的回顾性研究。
Sci Rep. 2024 Oct 14;14(1):23974. doi: 10.1038/s41598-024-74502-5.
9
Head-to-head comparison of azvudine and nirmatrelvir/ritonavir for the hospitalized patients with COVID-19: a real-world retrospective cohort study with propensity score matching.阿兹夫定与奈玛特韦/利托那韦治疗新型冠状病毒肺炎住院患者的头对头比较：一项倾向评分匹配的真实世界回顾性队列研究
Front Pharmacol. 2023 Oct 13;14:1274294. doi: 10.3389/fphar.2023.1274294. eCollection 2023.
10
A Real-World Retrospective Study on the Efficacy and Safety of Four Antiviral Drugs for Hospitalized COVID-19 Patients: Nirmatrelvir/Ritonavir, Simnotrelvir/Ritonavir, Molnupiravir and Azvudine.一项关于四种抗病毒药物用于住院 COVID-19 患者的疗效和安全性的真实世界回顾性研究：奈玛特韦/利托那韦、辛诺特韦/利托那韦、莫努匹拉韦和阿兹夫定。
Infect Drug Resist. 2024 Sep 14;17:3967-3978. doi: 10.2147/IDR.S477083. eCollection 2024.

引用本文的文献

1
Effectiveness of nirmatrelvir-ritonavir versus azvudine for adult inpatients with severe or critical COVID-19.奈玛特韦-利托那韦与阿兹夫定治疗成人重症或危重症 COVID-19 患者的有效性比较。
BMJ Open Respir Res. 2024 Apr 10;11(1):e001944. doi: 10.1136/bmjresp-2023-001944.
2
Inflammatory predictors (eosinophil, C-RP and IL-6) and effectiveness of oral Azvudine tablets treatment in COVID-19 hospitalized patients: A retrospective, self-controlled study.炎症预测指标（嗜酸性粒细胞、C反应蛋白和白细胞介素-6）及阿兹夫定片治疗COVID-19住院患者的有效性：一项回顾性自身对照研究。
Heliyon. 2023 Nov 7;9(11):e21941. doi: 10.1016/j.heliyon.2023.e21941. eCollection 2023 Nov.
3
Real-world effectiveness of azvudine for patients infected with the SARS-CoV-2 omicron subvariant BA.5 in an intensive care unit.
阿兹夫定对重症监护病房中感染新型冠状病毒奥密克戎亚型BA.5患者的真实世界有效性
J Thorac Dis. 2023 Sep 28;15(9):4925-4937. doi: 10.21037/jtd-23-1093. Epub 2023 Sep 25.